Read + Share
Barbier MC, Tomonaga Y, Menges D, Yebyo HG, et al. Survival modelling and cost-effectiveness analysis of treatments for newly
diagnosed metastatic hormone-sensitive prostate cancer. PLoS One 2022;17:e0277282.
PMID: 36327294
|
 |
|
Barbier MC, Tomonaga Y, Menges D, Yebyo HG, et al. Survival modelling and cost-effectiveness analysis of treatments for newly
diagnosed metastatic hormone-sensitive prostate cancer. PLoS One 2022;17:e0277282.
PMID: 36327294
|
|
|
|